RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+18.85%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.59B
AUM Growth
+$2.59B
(+13%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
3.85%
Top 10 Holdings %
Top 10 Hldgs %
46.26%
Holding
80
New
11
Increased
26
Reduced
24
Closed
16
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$78.7M |
| 2 |
Xencor
XNCR
|
$55.6M |
| 3 |
Atara Biotherapeutics
ATRA
|
$55.4M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$45.1M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$38.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$89.8M |
| 2 |
AstraZeneca
AZN
|
$70.1M |
| 3 |
CELG
Celgene Corp
CELG
|
$68.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$61.8M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$34.2M |
Sector Composition
| 1 | Healthcare | 92.32% |
| 2 | Financials | 0.74% |
| 3 | Communication Services | 0.37% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $281M | 10.85% | 17,224,428 -1,889,436 | -10% | -$30.8M |
|
|
2
Atara Biotherapeutics
ATRA
$84.6M
| $165M | 6.38% | 4,236,017 +1,420,029 | +50% | +$55.4M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $162M | 6.24% | 10,738,658 +712,888 | +7% | +$10.7M |
|
|
IMGN
4
DELISTED
Immunogen Inc
IMGN
| $102M | 3.94% | 9,702,482 -1,204,480 | -11% | -$12.7M |
|
|
5
Xencor
XNCR
$580M
| $96.1M | 3.71% | 3,204,343 +1,853,449 | +137% | +$55.6M |
|
6
Wave Life Sciences
WVE
$1.53B
| $89.7M | 3.46% | 2,237,607 +28,500 | +1% | +$1.14M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $82.6M | 3.19% | 6,505,766 | – | – |
|
|
AVXS
8
DELISTED
AveXis, Inc. Common Stock
AVXS
| $78.7M | 3.04% | +636,900 | New | +$78.7M |
|
9
Puma Biotechnology
PBYI
$254M
| $74.6M | 2.88% | 1,095,612 +182,039 | +20% | +$12.4M |
|
|
WCG
10
DELISTED
Wellcare Health Plans, Inc.
WCG
| $66.3M | 2.56% | 342,309 +197,960 | +137% | +$38.3M |
|
11
Abbott
ABT
$231B
| $65.7M | 2.54% | 1,096,100 +199,200 | +22% | +$11.9M |
|
12
Fate Therapeutics
FATE
$120M
| $65M | 2.51% | 6,655,962 +1,190,476 | +22% | +$11.6M |
|
13
Regenxbio
RGNX
$451M
| $63.6M | 2.46% | 2,130,972 +705,700 | +50% | +$21.1M |
|
14
Penumbra
PEN
$10.6B
| $63.3M | 2.44% | 547,079 -70,200 | -11% | -$8.12M |
|
15
Centene
CNC
$14.3B
| $59.8M | 2.31% | 559,800 +18,300 | +3% | +$1.96M |
|
16
AnaptysBio
ANAB
$569M
| $54.4M | 2.1% | 523,150 +293,300 | +128% | +$30.5M |
|
|
SYNH
17
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $54.2M | 2.09% | 1,526,104 +458,786 | +43% | +$16.3M |
|
18
ICU Medical
ICUI
$3.15B
| $48.8M | 1.89% | 193,472 +53,500 | +38% | +$13.5M |
|
19
Insmed
INSM
$28.8B
| $48.8M | 1.88% | 2,166,362 -82,900 | -4% | -$1.87M |
|
20
iRhythm Technologies
IRTC
$5.46B
| $45.9M | 1.77% | 729,874 -84,700 | -10% | -$5.33M |
|
21
LivaNova
LIVN
$3.08B
| $45.9M | 1.77% | 518,288 -97,300 | -16% | -$8.61M |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $45.6M | 1.76% | 267,100 +7,300 | +3% | +$1.25M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $45.1M | 1.74% | +404,800 | New | +$45.1M |
|
24
Teleflex
TFX
$5.59B
| $45M | 1.74% | 176,586 +4,100 | +2% | +$1.05M |
|
|
BOLD
25
DELISTED
Audentes Therapeutics, Inc
BOLD
| $39.3M | 1.52% | 1,308,526 +379,200 | +41% | +$11.4M |
|